If diabetes can be delayed, even for a few years, those at risk may be able to postpone the difficult challenges of trying to control their glucose levels and the potential development of serious complications. The serious complications of diabetes include heart disease, stroke, blindness, kidney damage and lower-limb amputations
In addition, Type 1 Diabetes TrialNet is preparing to launch several new studies in early 2008 for people newly diagnosed with type 1 diabetes. The group is also collaborating with the Immune Tolerance Network, also funded by NIH, to perform studies aimed at the protection of beta cells in people recently diagnosed with type 1 diabetes.
These researchers are working together to answer such critical questions as:
-- Can insulin taken by mouth once a day prevent or delay type 1 diabetes
in some people at risk for the disease?
-- Is it possible to turn off the body's immune attack that causes type 1
diabetes by administering certain antibodies that bind to and
temporarily destroy a specific class of immune cells?
-- Can certain drugs or combinations of drugs slow or arrest the
autoimmune response in type 1 diabetes?
-- Can an omega-3 fatty acid, naturally found in a mothers' breast milk
and some foods, have anti-inflammatory benefits that can prevent or
delay development of the autoimmunity leading to type 1 diabetes?
To learn more about free screening for type 1 diabetes risk and studies, call 1-800-HALT-DM1 (1-800-425-8361) or visit http://www.DiabetesTrialNet.org.
MEDIA TELECONFERENCE ON TYPE 1 DIABETES; NOVEMBER 14, 12-1:30 PM
On World Diabetes Day, November 14, from 12:00-1:30 p.m., a panel of
internationally renowned type 1 diabetes experts will present an overview
of the latest findings and theories an
|SOURCE Diabetes TrialNet|
Copyright©2007 PR Newswire.
All rights reserved